Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Pharm ; 15(5): 1878-1891, 2018 05 07.
Artículo en Inglés | MEDLINE | ID: mdl-29590755

RESUMEN

The field of tissue engineering is increasingly recognizing that gene therapy can be employed for modulating in vivo cellular response thereby guiding tissue regeneration. However, the field lacks a versatile and biocompatible gene delivery platform capable of efficiently delivering transgenes to mesenchymal stem cells (MSCs), a cell type often refractory to transfection. Herein, we describe the extensive and systematic exploration of three architectural variations of star-shaped poly(l-lysine) polypeptide (star-PLL) with varying number and length of poly(l-lysine) arms as potential nonviral gene delivery vectors for MSCs. We demonstrate that star-PLL vectors are capable of self-assembling with pDNA to form stable, cationic nanomedicines. Utilizing high content screening, live cell imaging, and mechanistic uptake studies we confirm the intracellular delivery of pDNA by star-PLLs to MSCs is a rapid process, which likely proceeds via a clathrin-independent mechanism. We identify a star-PLL composition with 64 poly(l-lysine) arms and five l-lysine subunits per arm as a particularly efficient vector that is capable of delivering both reporter genes and the therapeutic transgenes bone morphogenetic protein-2 and vascular endothelial growth factor to MSCs. This composition facilitated a 1000-fold increase in transgene expression in MSCs compared to its linear analogue, linear poly(l-lysine). Furthermore, it demonstrated comparable transgene expression to the widely used vector polyethylenimine using a lower pDNA dose with significantly less cytotoxicity. Overall, this study illustrates the ability of the star-PLL vectors to facilitate efficient, nontoxic nucleic acid delivery to MSCs thereby functioning as an innovative nanomedicine platform for tissue engineering applications.


Asunto(s)
ADN/administración & dosificación , ADN/química , Portadores de Fármacos/química , Células Madre Mesenquimatosas/efectos de los fármacos , Nanopartículas/química , Péptidos/química , Polilisina/química , Animales , Proteína Morfogenética Ósea 2/genética , Células Cultivadas , Clatrina/genética , Sistemas de Liberación de Medicamentos/métodos , Técnicas de Transferencia de Gen , Genes Reporteros/genética , Terapia Genética/métodos , Vectores Genéticos/genética , Ácidos Nucleicos/genética , Polietileneimina/química , Polímeros/química , Ratas , Ingeniería de Tejidos/métodos , Transfección/métodos , Transgenes/genética , Factor A de Crecimiento Endotelial Vascular/genética
2.
J Cell Sci ; 128(13): 2339-49, 2015 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-25999475

RESUMEN

Here, we describe a high-content microscopy-based screen that allowed us to systematically assess and rank proteins involved in Golgi-to-endoplasmic reticulum (ER) retrograde transport in mammalian cells. Using a cell line stably expressing a GFP-tagged Golgi enzyme, we used brefeldin A treatment to stimulate the production of Golgi-to-ER carriers and then quantitatively analysed populations of cells for changes in this trafficking event. Systematic RNA interference (RNAi)-based depletion of 58 Rab GTPase proteins and 12 Rab accessory proteins of the PRAF, YIPF and YIF protein families revealed that nine of these were strong regulators. In addition to demonstrating roles for Rab1a, Rab1b, Rab2a, and Rab6a or Rab6a' in this transport step, we also identified Rab10 and Rab11a as playing a role and being physically present on a proportion of the Golgi-to-ER tubular intermediates. Combinatorial depletions of Rab proteins also revealed previously undescribed functional co-operation and physical co-occurrence between several Rab proteins. Our approach therefore provides a novel and robust strategy for a more complete investigation of the molecular components required to regulate Golgi-to-ER transport in mammalian cells.


Asunto(s)
Retículo Endoplásmico/metabolismo , Aparato de Golgi/metabolismo , Microscopía/métodos , Proteínas de Unión al GTP rab/metabolismo , Bioensayo , Transporte Biológico , Proteínas Fluorescentes Verdes/metabolismo , Células HeLa , Humanos , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Reproducibilidad de los Resultados
3.
Nat Commun ; 7: 10855, 2016 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-26927507

RESUMEN

Bioresponsive NIR-fluorophores offer the possibility for continual visualization of dynamic cellular processes with added potential for direct translation to in vivo imaging. Here we show the design, synthesis and lysosome-responsive emission properties of a new NIR fluorophore. The NIR fluorescent probe design differs from typical amine functionalized lysosomotropic stains with off/on fluorescence switching controlled by a reversible phenol/phenolate interconversion. Emission from the probe is shown to be highly selective for the lysosomes in co-imaging experiments using a HeLa cell line expressing the lysosomal-associated membrane protein 1 fused to green fluorescent protein. The responsive probe is capable of real-time continuous imaging of fundamental cellular processes such as endocytosis, lysosomal trafficking and efflux in 3D and 4D. The advantage of the NIR emission allows for direct translation to in vivo tumour imaging, which is successfully demonstrated using an MDA-MB-231 subcutaneous tumour model. This bioresponsive NIR fluorophore offers significant potential for use in live cellular and in vivo imaging, for which currently there is a deficit of suitable molecular fluorescent tools.


Asunto(s)
Colorantes Fluorescentes/química , Lisosomas/metabolismo , Imagen Óptica/métodos , Espectroscopía Infrarroja Corta/métodos , Adenocarcinoma/metabolismo , Animales , Neoplasias de la Mama , Comunicación Celular , Línea Celular Tumoral , Femenino , Colorantes Fluorescentes/síntesis química , Humanos , Ratones , Microscopía Fluorescente , Estructura Molecular , Neoplasias Experimentales/metabolismo
4.
Sci Rep ; 6: 28865, 2016 07 04.
Artículo en Inglés | MEDLINE | ID: mdl-27374232

RESUMEN

Synthetic nanoparticles are promising tools for imaging and drug delivery; however the molecular details of cellular internalization and trafficking await full characterization. Current knowledge suggests that following endocytosis most nanoparticles pass from endosomes to lysosomes. In order to design effective drug delivery strategies that can use the endocytic pathway, or by-pass lysosomal accumulation, a comprehensive understanding of nanoparticle uptake and trafficking mechanisms is therefore fundamental. Here we describe and apply an RNA interference-based high-content screening microscopy strategy to assess the intracellular trafficking of fluorescently-labeled polystyrene nanoparticles in HeLa cells. We screened a total of 408 genes involved in cytoskeleton and membrane function, revealing roles for myosin VI, Rab33b and OATL1 in this process. This work provides the first systematic large-scale quantitative assessment of the proteins responsible for nanoparticle trafficking in cells, paving the way for subsequent genome-wide studies.


Asunto(s)
Proteínas Activadoras de GTPasa/metabolismo , Cadenas Pesadas de Miosina/metabolismo , Proteínas de Unión al GTP rab/metabolismo , Transporte Biológico , Citoesqueleto/metabolismo , Sistemas de Liberación de Medicamentos , Genoma Humano , Células HeLa , Humanos , Proteínas de Membrana de los Lisosomas/metabolismo , Lisosomas/metabolismo , Microscopía/métodos , Nanopartículas/química , Nanotecnología , Interferencia de ARN , ARN Interferente Pequeño/metabolismo , Proteínas de Transporte Vesicular/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA